MARY D'AMICO: Open Payments
NPI 1710312533 · DANIELSON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,830 in 101 payments from 23 companies in 2025. Trend: 2023 $2,689 · 2024 $2,497 · 2025 $1,830
Food & beverage: $1,807Education: $24
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $429 |
| Vanda Pharmaceuticals Inc. | 10 | $192 |
| Otsuka America Pharmaceutical, Inc. | 7 | $154 |
| Novo Nordisk Inc | 8 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $119 |
| Amgen Inc. | 5 | $95 |
| AstraZeneca Pharmaceuticals LP | 5 | $91 |
| Exact Sciences Corporation | 3 | $69 |
| Lundbeck LLC | 4 | $64 |
| Lilly USA, LLC | 3 | $63 |
Products named: REXULTI, VRAYLAR, FANAPT, CAPLYTA, QULIPTA, UBRELVY, Cologuard Collection Kit, EVENITY.
Industry payments across CT — which companies pay providers there.
